Kaposi's sarcoma of the head and neck: A review

Oral Oncology

Volumn 46, Issue 3, 2010, Pages 135-145

  Ramírez Amador, Velia ^a   Anaya Saavedra, Gabriela ^a   Martínez Mata, Guillermo ^b  

^a DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE CHIHUAHUA   (Mexico)

Author keywords

AIDS; Clonality; Head and neck; HIV; Human herpesvirus 8; Kaposi's sarcoma; Oral; Pathogenesis; Saliva; Therapy

Indexed keywords

ALITRETINOIN; ALPHA INTERFERON; ANTHRACYCLINE; DAUNORUBICIN; DOXORUBICIN; PACLITAXEL; VINBLASTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICAN ENDEMIC KAPOSI SARCOMA; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CLASSIC KAPOSI SARCOMA; CLINICAL FEATURE; CRYOTHERAPY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; HEAD AND NECK CANCER; HERPES VIRUS INFECTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; ORGAN TRANSPLANTATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SALIVA; SPINDLE CELL; VIRUS TRANSMISSION;

AFRICA; BRAZIL; FEMALE; HEAD AND NECK NEOPLASMS; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HIV-1; HUMANS; MALE; MEDITERRANEAN REGION; SARCOMA, KAPOSI;

EID: 76749110987     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2009.12.006     Document Type: Review

References (228)

1. Ramírez-Amador V., Martínez-Mata G., González-Ramírez I., Anaya-Saavedra G., and de Almeida O.P. Clinical, histological and immunohistochemical findings in oral Kaposi's sarcoma in a series of Mexican AIDS patients. Comparative study. J Oral Pathol Med 38 4 (2009) 328-333
2. Feller L., Wood N.H., and Lemmer J. HIV-associated Kaposi sarcoma: pathogenic mechanisms. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104 4 (2007) 521-529
3. Fletcher C.D. The evolving classification of soft tissue tumours: an update based on the new WHO classification. Histopathology 48 1 (2006) 3-12
4. Schwartz R.A., Micali G., Nasca M.R., and Scuderi L. Kaposi sarcoma: a continuing conundrum. J Am Acad Dermatol 59 2 (2008) 179-206
5. Szajerka T., and Jablecki J. Kaposi's sarcoma revisited. AIDS Rev 9 4 (2007) 230-236
6. Lanternier F., Lebbé C., Schartz N., Farhi D., Marcelin A.G., Kérob D., et al. Kaposi's sarcoma in HIV-negative men having sex with men. AIDS 22 10 (2008) 1163-1168
7. Sissolak G., and Mayaud P. AIDS-related Kaposi's sarcoma: epidemiological, diagnostic, treatment and control aspects in sub-Saharan Africa. Trop Med Int Health 10 10 (2005) 981-992
8. Chokunonga E., Levy L.M., Bassett M.T., Mauchaza B.G., Thomas D.B., and Parkin D.M. Cancer incidence in the African population of Harare, Zimbabwe: second results from the cancer registry 1993-1995. Int J Cancer 85 1 (2000) 54-59
9. Bagni R., and Whitby D. Kaposi's sarcoma-associated herpesvirus transmission and primary infection. Curr Opin HIVAIDS 4 1 (2009) 22-26
10. Pica F., and Volpi A. Transmission of human herpesvirus 8: an update. Curr Opin Infect Dis 20 2 (2007) 152-156
11. Dukers N.H., and Rezza G. Human herpesvirus 8 epidemiology: what we do and do not know. AIDS 17 12 (2003) 1717-1730
12. Duprez R., Lacoste V., Brière J., Couppié P., Frances C., Sainte-Marie D., et al. Evidence for a multiclonal origin of multicentric advanced lesions of Kaposi sarcoma. J Natl Cancer Inst 99 14 (2007) 1086-1094
13. Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., Knowles D.M., et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266 5192 (1994) 1865-1869
14. Nakamura H., Lu M., Gwack Y., Souvlis J., Zeichner S.L., and Jung J.U. Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator. J Virol 77 7 (2003) 4205-4220
15. Dubina M., and Goldenberg G. Positive staining of tumor-stage Kaposi sarcoma with lymphatic marker D2-40. J Am Acad Dermatol 61 2 (2009) 276-280
16. Long E., Ilie M., Hofman V., Havet K., Selva E., Butori C., et al. LANA-1, Bcl-2, Mcl-1 and HIF-1alpha protein expression in HIV-associated Kaposi sarcoma. Virchows Arch 455 2 (2009) 159-170
17. Montaner S. Akt/TSC/mTOR activation by the KSHV G protein-coupled receptor: emerging insights into the molecular oncogenesis and treatment of Kaposi's sarcoma. Cell Cycle 6 4 (2007) 438-443
18. Moses A.V., Jarvis M.A., Raggo C., Bell Y.C., Ruhl R., Luukkonen B.G., et al. Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells. J Virol 76 16 (2002) 8383-8399
19. Barillari G., Sgadari C., Palladino C., Gendelman R., Caputo A., Morris C.B., et al. Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin. J Immunol 163 4 (1999) 1929-1935
20. Stürzl M., Hohenadl C., Zietz C., Castanos-Velez E., Wunderlich A., Ascherl G., et al. Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells. J Natl Cancer Inst 91 20 (1999) 1725-1733
21. Arav-Boger R. Treatment for Kaposi sarcoma herpesvirus: great challenges with promising accomplishments. Virus Genes 38 2 (2009) 195-203
22. Di Lorenzo G., Konstantinopoulos P.A., Pantanowitz L., Di Trolio R., De Placido S., and Dezube B.J. Management of AIDS-related Kaposi's sarcoma. Lancet Oncol 8 2 (2007) 167-176
23. Di Lorenzo G. Update on classic Kaposi sarcoma therapy: new look at an old disease. Crit Rev Oncol Hematol 68 3 (2008) 242-249
24. Dal Maso L., Polesel J., Ascoli V., Zambon P., Budroni M., Ferretti S., et al. Cancer and AIDS registry linkage study. Classic Kaposi's sarcoma in Italy, 1985-1998. Br J Cancer 92 1 (2005) 188-193
25. Vitale F., Briffa D.V., Whitby D., Maida I., Grochowska A., Levin A., et al. Kaposi's sarcoma herpes virus and Kaposi's sarcoma in the elderly populations of 3 Mediterranean islands. Int J Cancer 91 4 (2001) 588-591
26. Iscovich J., Boffetta P., Winkelmann R., Brennan P., and Azizi E. Classic Kaposi's sarcoma in Jews living in Israel, 1961-1989: a population-based incidence study. AIDS 12 15 (1998) 2067-2072
27. Iscovich J., Boffetta P., and Brennan P. Classic Kaposi's sarcoma in Arabs living in Israel, 1970-1993: a population-based incidence study. Int J Cancer 77 3 (1998) 319-321
28. Grulich A.E., Beral V., and Swerdlow A.J. Kaposi's sarcoma in England and Wales before the AIDS epidemic. Br J Cancer 66 6 (1992) 1135-1137
29. Mosam A., Carrara H., Shaik F., Uldrick T., Berkman A., Aboobaker J., et al. Increasing incidence of Kaposi's sarcoma in black South Africans in KwaZulu-Natal, South Africa (1983-2006). Int J STD AIDS 20 8 (2009) 553-556
30. Wabinga H.R., Parkin D.M., Wabwire-Mangen F., and Nambooze S. Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997. Br J Cancer 82 9 (2000) 1585-1592
31. Parkin D.M., Vizcaino A.P., Skinner M.E., and Ndhlovu A. Cancer patterns and risk factors in the African population of southwestern Zimbabwe, 1963-1977. Cancer Epidemiol Biomarkers Prev 3 7 (1994) 537-547
32. Wabinga H.R., Parkin D.M., Wabwire-Mangen F., and Mugerwa J.W. Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS. Int J Cancer 54 1 (1993) 26-36
33. Parkin D.M., Sitas F., Chirenje M., Stein L., Abratt R., and Wabinga H. Part I: Cancer in Indigenous Africans-burden, distribution, and trends. Lancet Oncol 9 7 (2008) 683-692
34. Chokunonga E., Levy L.M., Bassett M.T., Borok M.Z., Mauchaza B.G., and Chirenje M.Z. Aids and cancer in Africa the evolving epidemic in Zimbabwe. AIDS 13 18 (1999) 2583-2588
35. Ziegler J.L., and Katongole-Mbidde E. Kaposi's sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection. Int J Cancer 65 2 (1996) 200-203
36. Mocroft A., Kirk O., Clumeck N., Gargalianos-Kakolyris P., Trocha H., Chentsova N., et al. The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA Study. Cancer 100 12 (2004) 2644-2654
37. Serraino D., Angeletti C., Carrieri M.P., Longo B., Piche M., Piselli P., et al. for the Immunesuppression and Cancer Study Group. Kaposi's sarcoma in transplant and HIV-infected patients: an epidemiologic study in Italy and France. Transplantation 80 12 (2005) 1699-1704
38. Parkin D.M. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118 12 (2006) 3030-3044
39. Atkinson J.O., Biggar R.J., Goedert J.J., and Engels E.A. The incidence of Kaposi sarcoma among injection drug users with AIDS in the United States. J Acquir Immune Defic Syndr 37 2 (2004) 1282-1287
40. Eltom M.A., Jemal A., Mbulaiteye S.M., Devesa S.S., and Biggar R.J. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst 94 16 (2002) 1204-1210
41. Jones J.L., Hanson D.L., Dworkin M.S., and Jaffe H.W. Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy. J Acquir Immune Defic Syndr 24 3 (2000) 270-274
42. Mbulaiteye S.M., and Engels E.A. Kaposi's sarcoma risk among transplant recipients in the United States (1993-2003). Int J Cancer 119 11 (2006) 2685-2691
43. Tessari G., Naldi L., Boschiero L., Cordiano C., Piaserico S., Fortina A.B., et al. Incidence and clinical predictors of Kaposi's sarcoma among 1721 Italian solid organ transplant recipients: a multicenter study. Eur J Dermatol 16 5 (2006) 553-557
44. Simonart T. Role of environmental factors in the pathogenesis of classic and African-endemic Kaposi sarcoma. Cancer Lett 244 1 (2006) 1-7
45. Mohanna S., Maco V., Bravo F., and Gotuzzo E. Epidemiology and clinical characteristics of classic Kaposi's sarcoma, seroprevalence, and variants of human herpesvirus 8 in South America: a critical review of an old disease. Int J Infect Dis 9 5 (2005) 239-250
46. Cook-Mozaffari P., Newton R., Beral V., and Burkitt D.P. The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic. Br J Cancer 78 11 (1998) 1521-1528
47. Chintu C., Athale U.H., and Patil P.S. Childhood cancers in Zambia before and after the HIV epidemic. Arch Dis Child 73 2 (1995) 100-104
48. Dedicoat M., and Newton R. Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma. Br J Cancer 88 1 (2003) 1-3
49. Sinfield R.L., Molyneux E.M., Banda K., Borgstein E., Broadhead R., Hesseling P., et al. Spectrum and presentation of pediatric malignancies in the HIV era: experience from Blantyre, Malawi, 1998-2003. Pediatr Blood Cancer 48 5 (2007) 515-520
50. Athale U.H., Patil P.S., Chintu C., and Elem B. Influence of HIV epidemic on the incidence of Kaposi's sarcoma in Zambian children. J Acquir Immune Defic Syndr Hum Retrovirol 8 1 (1995) 96-100
51. Antman K., and Chang Y. Kaposi's sarcoma. New Engl J Med 342 14 (2000) 1027-1038
52. Mwanda O.W., Fu P., Collea R., Whalen C., and Remick S.C. Kaposi's sarcoma in patients with and without human immunodeficiency virus infection, in a tertiary referral centre in Kenya. Ann Trop Med Parasitol 99 1 (2005) 81-91
53. Olweny C.L., Borok M., Gudza I., Clinch J., Cheang M., Kiire C.F., et al. Treatment of AIDS-associated Kaposi's sarcoma in Zimbabwe: results of a randomized quality of life focused clinical trial. Int J Cancer 113 4 (2005) 632-639
54. Leidner R.S., and Aboulafia D.M. Recrudescent Kaposi's sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome. AIDS Patient Care STDS 19 10 (2005) 635-644
55. Crane H.M., Deubner H., Huang J.C., Swanson P.E., and Harrington R.D. Fatal Kaposi's sarcoma-associated immune reconstitution following HAART initiation. Int J STD AIDS 16 1 (2005) 80-83
56. Papagatsia Z., Jones J., Morgan P., and Tappuni A.R. Oral Kaposi sarcoma: a case of immune reconstitution inflammatory syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108 1 (2009) 70-75
57. Ramírez-Amador V.A., Espinosa E., González-Ramírez I., Anaya-Saavedra G., Ormsby C.E., and Reyes-Terán G. Identification of oral candidosis, hairy leukoplakia and recurrent oral ulcers as distinct cases of immune reconstitution inflammatory syndrome. Int J STD AIDS 20 4 (2009) 259-261
58. Feller L., Anagnostopoulos C., Wood N.H., Bouckaert M., Raubenheimer E.J., and Lemmer J. Human immunodeficiency virus-associated Kaposi sarcoma as an immune reconstitution inflammatory syndrome: a literature review and case report. J Periodontol 79 2 (2008) 362-368
59. Bower M., Nelson M., Young A.M., Thirlwell C., Newsom-Davis T., Mandalia S., et al. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. J Clin Oncol 23 22 (2005) 5224-5228
60. Buonaguro F.M., Tomesello M.L., Buonaguro L., Satriano R.A., Ruocco E., Castello G., et al. Kaposi's sarcoma: aetiopathogenesis, histology and clinical features. J Eur Acad Dermatol Venereol 17 2 (2003) 138-154
61. Mendez J.C., and Paya C.V. Kaposi's sarcoma and transplantation. Herpes 7 (2000) 1
62. Lebbé C., Legendre C., and Francès C. Kaposi sarcoma in transplantation. Transplant Rev (Orlando) 22 4 (2008) 252-261
63. Parravicini C., Olsen S.J., Capra M., Poli F., Sirchia G., Gao S.J., et al. Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients. Blood 90 7 (1997) 2826-2829
64. National Cancer Institute. Kaposi sarcoma treatment. Health Professional Version. [accessed 11.10.09].
65. Piselli P., Busnach G., Citterio F., Frigerio M., Arbustini E., Burra P., et al. Immunosuppression and Cancer Study Group. Risk of Kaposi sarcoma after solid-organ transplantation: multicenter study in 4767 recipients in Italy, 1970-2006. Transplant Proc 41 4 (2009) 1227-1230
66. Ganem D. KSHV infection and the pathogenesis of Kaposi's sarcoma. Annu Rev Pathol 1 (2006) 273-296
67. Buonaguro F.M., Tornesello M.L., Beth-Giraldo E., Hatzakis A., Mueller N., Downing R., et al. Herpesvirus-like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsies. Int J Cancer 65 1 (1996) 25-28
68. Whitby D., Howard M.R., Tenant-Flowers M., Brink N.S., Copas A., Boshoff C., et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 346 8978 (1995) 799-802
69. Lefrère J.J., Meyohas M.C., Mariotti M., Meynard J.L., Thauvin M., and Frottier J. Detection of human herpesvirus 8 DNA sequences before the appearance of Kaposi's sarcoma in human immunodeficiency virus (HIV)-positive subjects with a known date of HIV seroconversion. J Infect Dis 174 2 (1996) 283-287
70. Gao S.J., Kingsley L., Hoover D.R., Spira T.J., Rinaldo C.R., Saah A., et al. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. New Engl J Med 335 4 (1996) 233-241
71. Anderson L.A., Lauria C., Romano N., Brown E.E., Whitby D., Graubard B.I., et al. Risk factors for classical Kaposi sarcoma in a population-based case-control study in Sicily. Cancer Epidemiol Biomarkers Prev 17 12 (2008) 3435-3443
72. Mancuso R., Biffi R., Valli M., Bellinvia M., Tourlaki A., Ferrucci S., et al. HHV8 a subtype is associated with rapidly evolving classic Kaposi's sarcoma. J Med Virol 80 12 (2008) 2153-2160
73. Ramos-da-Silva S., Elgui-de-Oliveira D., Borges L., and Bacchi C.E. Kaposi's sarcoma-associated herpesvirus infection and Kaposi's sarcoma in Brazil. Braz J Med Biol Res 39 5 (2006) 573-580
74. Guttman-Yassky E., Dubnov J., Kra-Oz Z., Friedman-Birnbaum R., Silbermann M., Barchana M., et al. Classic Kaposi sarcoma. Which KSHV-seropositive individuals are at risk? Cancer 106 2 (2006) 413-419
75. Guttman-Yassky E., Kra-Oz Z., Dubnov J., Friedman-Birnbaum R., Segal I., Zaltzman N., et al. Infection with Kaposi's sarcoma-associated herpesvirus among families of patients with classic Kaposi's sarcoma. Arch Dermatol 141 11 (2005) 1429-1434
76. Hbid O., Belloul L., Fajali N., Ismaili N., Duprez R., Tanguy M., et al. Kaposi's sarcoma in Morocco: a pathological study with immunostaining for human herpesvirus-8 LNA-1. Pathology 37 4 (2005) 288-295
77. Dilnur P., Katano H., Wang Z.H., Osakabe Y., Kudo M., Sata T., et al. Classic type of Kaposi's sarcoma and human herpesvirus 8 infection in Xinjiang, China. Pathol Int 51 11 (2001) 845-852
78. Angeloni A., Heston L., Uccini S., Sirianni M.C., Cottoni F., Masala M.V., et al. High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi's sarcoma from Sardinia. J Infect Dis 177 6 (1998) 1715-1718
79. Chatlynne L.G., Lapps W., Handy M., Huang Y.Q., Masood R., Hamilton A.S., et al. Detection and titration of human herpesvirus-8-specific antibodies in sera from blood donors, acquired immunodeficiency syndrome patients, and Kaposi's sarcoma patients using a whole virus enzyme-linked immunosorbent assay. Blood 92 1 (1998) 53-58
80. Cathomas G., McGandy C.E., Terracciano L.M., Itin P.H., De Rosa G., and Gudat F. Detection of herpesvirus-like DNA by nested PCR on archival skin biopsy specimens of various forms of Kaposi sarcoma. J Clin Pathol 49 8 (1996) 631-633
81. Simpson G.R., Schulz T.F., Whitby D., Cook P.M., Boshoff C., Rainbow L., et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 348 9035 (1996) 1133-1138
82. Wamburu G., Masenga E.J., Moshi E.Z., Schmid-Grendelmeier P., Kempf W., and Orfanos C.E. HIV-associated and non-HIV associated types of Kaposi's sarcoma in an African population in Tanzania. Status of immune suppression and HHV-8 seroprevalence. Eur J Dermatol 16 6 (2006) 677-682
83. Schwartz E.J., Dorfman R.F., and Kohler S. Human herpesvirus-8 latent nuclear antigen-1 expression in endemic Kaposi sarcoma: an immunohistochemical study of 16 cases. Am J Surg Pathol 27 12 (2003) 1546-1550
84. Fouchard N., Lacoste V., Couppie P., Develoux M., Mauclere P., Michel P., et al. Detection and genetic polymorphism of human herpes virus type 8 in endemic or epidemic Kaposi's sarcoma from West and Central Africa, and South America. Int J Cancer 85 2 (2000) 166-170
85. Kennedy M.M., Lucas S.B., Jones R.R., Howells D.D., Picton S.J., Hanks E.E., et al. HHV8 and Kaposi's sarcoma: a time cohort study. Mol Pathol 50 2 (1997) 96-100
86. Kasolo F.C., Mpabalwani E., and Gompels U.A. Infection with AIDS-related herpesviruses in human immunodeficiency virus-negative infants and endemic childhood Kaposi's sarcoma in Africa. J Gen Virol 78 Pt 4 (1997) 847-855
87. Johnston C., Orem J., Okuku F., Kalinaki M., Saracino M., Katongole-Mbidde E., et al. Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in Uganda. PLoS One 4 1 (2009) e4222
88. Kumar N., McLean K., Inoue N., Moles D.R., Scully C., Porter S.R., et al. Human herpesvirus 8 genoprevalence in populations at disparate risks of Kaposi's sarcoma. J Med Virol 79 1 (2007) 52-59
89. Laney A.S., Cannon M.J., Jaffe H.W., Offermann M.K., Ou C.Y., Radford K.W., et al. Human herpesvirus 8 presence and viral load are associated with the progression of AIDS-associated Kaposi's sarcoma. AIDS 21 12 (2007) 1541-1545
90. Sitas F., Carrara H., Beral V., Newton R., Reeves G., Bull D., et al. Antibodies against human herpesvirus 8 in black South African patients with cancer. New Engl J Med 340 24 (1999) 1863-1871
91. Zhu L., Wang R., Sweat A., Goldstein E., Horvat R., and Chandran B. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells. Virology 256 2 (1999) 381-392
92. Rezza G., Lennette E.T., Giuliani M., Pezzotti P., Caprilli F., Monini P., et al. Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections. Int J Cancer 77 3 (1998) 361-365
93. Lin S.F., Sun R., Heston L., Gradoville L., Shedd D., Haglund K., et al. Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen. J Virol 71 4 (1997) 3069-3076
94. Zhang X., Fitzpatrick L., Campbell T.B., Badaro R., Schechter M., Melo M., et al. Comparison of the prevalence of antibodies to human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) in Brazil and Colorado. J Infect Dis 178 5 (1998) 1488-1491
95. Al-Otaibi L.M., Al-Sulaiman M.H., Teo C.G., and Porter S.R. Extensive oral shedding of human herpesvirus 8 in a renal allograft recipient. Oral Microbiol Immunol 24 2 (2009) 109-115
96. Zavos G., Bokos J., Papaconstantinou I., Boletis J., Gazouli M., Kakisis J., et al. Clinicopathological aspects of 18 Kaposi's sarcoma among 1055 Greek renal transplant recipients. Artif Organs 28 6 (2004) 595-599
97. Briz M., Alonso-Pulpon L., Crespo-Leiro M.G., Exposito C., Almagro M., Busto M.J., et al. Detection of herpesvirus-like sequences in Kaposi's sarcoma from heart transplant recipients. J Heart Lung Transplant 17 3 (1998) 288-293
98. Rady P.L., Hodak E., Yen A., Memar O., Trattner A., Feinmesser M., et al. Detection of human herpesvirus-8 DNA in Kaposi's sarcomas from iatrogenically immunosuppressed patients. J Am Acad Dermatol 38 3 (1998) 429-437
99. Alkan S., Karcher D.S., Ortiz A., Khalil S., Akhtar M., and Ali M.A. Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus in organ transplant patients with immunosuppression. Br J Haemato 96 2 (1997) 412-414
100. Giuliani M., Cordiali-Fei P., Castilletti C., Di Carlo A., Palamara G., Boros S., et al. Incidence of human herpesvirus 8 (HHV-8) infection among HIV-uninfected individuals at high risk for sexually transmitted infections. BMC Infect Dis 7 (2007) 143
101. Martró E., Esteve A., Schulz T.F., Sheldon J., Gambús G., Muñoz R., et al. For the Euro-Shaks study group. Risk factors for human Herpesvirus 8 infection and AIDS-associated Kaposi's sarcoma among men who have sex with men in a European multicentre study. Int J Cancer 120 5 (2007) 1129-1135
102. Ablashi D., Chatlynne L., Cooper H., Thomas D., Yadav M., Norhanom A.W., et al. Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa. Br J Cancer 81 5 (1999) 893-897
103. Bélec L., Cancré N., Hallouin M.C., Morvan J., Si Mohamed A., and Grésenguet G. High prevalence in Central Africa of blood donors who are potentially infectious for human herpesvirus 8. Transfusion 38 8 (1998) 771-775
104. He J., Bhat G., Kankasa C., Chintu C., Mitchell C., Duan W., et al. Seroprevalence of human herpesvirus 8 among Zambian women of childbearing age without Kaposi's sarcoma (KS) and mother-child pairs with KS. J Infect Dis 178 6 (1998) 1787-1790
105. Olsen S.J., Chang Y., Moore P.S., Biggar R.J., and Melbye M. Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985. AIDS 12 14 (1998) 1921-1925
106. de Souza V.A., Sumita L.M., Nascimento M.C., Oliveira J., Mascheretti M., Quiroga M., et al. Human herpesvirus-8 infection and oral shedding in Amerindian and non-Amerindian populations in the Brazilian Amazon region. J Infect Dis 196 6 (2007) 844-852
107. Batista M.D., Ferreira S., Sauer M.M., Tomiyama H., Giret M.T., Pannuti C.S., et al. High human herpesvirus 8 (HHV-8) prevalence, clinical correlates and high incidence among recently HIV-1-infected subjects in Sao Paulo, Brazil. PLoS One 4 5 (2009) e5613
108. Fu B., Sun F., Li B., Yang L., Zeng Y., Sun X., et al. Seroprevalence of Kaposi's sarcoma-associated herpesvirus and risk factors in Xinjiang, China. J Med Virol 81 8 (2009) 1422-1431
109. Guanira J.V., Casper C., Lama J.R., Morrow R., Montano S.M., Caballero P., et al. For the Peruvian HIV Sentinel Surveillance Working Group. Prevalence and correlates of human herpesvirus 8 infection among Peruvian men who have sex with men. J Acquir Immune Defic Syndr 49 5 (2008) 557-562
110. Widmer I.C., Erb P., Grob H., Itin P., Baumann M., Stalder A., et al. Human herpesvirus 8 oral shedding in HIV-infected men with and without Kaposi sarcoma. J Acquir Immune Defic Syndr 42 4 (2006) 420-425
111. Cannon M.J., Dollard S.C., Smith D.K., Klein R.S., Schuman P., Rich J.D., et al. HIV Epidemiology Research Study Group. Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection. New Engl J Med 344 9 (2001) 637-643
112. Perna A.M., Bonura F., Vitale F., Viviano E., Di Benedetto M.A., Ajello F., et al. Antibodies to human herpes virus type 8 (HHV8) in general population and in individuals at risk for sexually transmitted diseases in Western Sicily. Int J Epidemiol 29 1 (2000) 175-179
113. Lennette E.T., Blackbourn D.J., and Levy J.A. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 348 9031 (1996) 858-861
114. Casper C., Wald A., Pauk J., Tabet S.R., Corey L., and Celum C.L. Correlates of prevalent and incident Kaposi's sarcoma-associated herpesvirus infection in men who have sex with men. J Infect Dis 185 7 (2002) 990-993
115. Martin J.N., Ganem D.E., Osmond D.H., Page-Shafer K.A., Macrae D., and Kedes D.H. Sexual transmission and the natural history of human herpesvirus 8 infection. New Engl J Med 338 14 (1998) 948-954
116. Casper C., Carrell D., Miller K.G., Judson F.D., Meier A.S., Pauk J.S., et al. HIV serodiscordant sex partners and the prevalence of human herpesvirus 8 infection among HIV negative men who have sex with men: baseline data from the EXPLORE Study. Sex Transm Infect 82 3 (2006) 229-235
117. Grulich A.E., Cunningham P., Munier M.L., Prestage G., Amin J., Ringland C., et al. Sexual behaviour and human herpesvirus 8 infection in homosexual men in Australia. Sex Health 2 1 (2005) 13-18
118. Dukers N.H., Renwick N., Prins M., Geskus R.B., Schulz T.F., Weverling G.J., et al. Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men. Am J Epidemiol 151 3 (2000) 213-224
119. Grulich A.E., Kaldor J.M., Hendry O., Luo K., Bodsworth N.J., and Cooper D.A. Risk of Kaposi's sarcoma and oroanal sexual contact. Am J Epidemiol 145 8 (1997) 673-679
120. Baeten J.M., Chohan B.H., Lavreys L., Rakwar J.P., Ashley R., Richardson B.A., et al. Correlates of human herpesvirus 8 seropositivity among heterosexual men in Kenya. AIDS 16 15 (2002) 2073-2078
121. McDonald A.C., Ragin C.C., Jenkins F.J., Weissfeld J., Wilson J., Wheeler V.W., et al. Human herpesvirus 8 seroprevalence among Tobago women and the role of sexual lifestyle behavior. J Med Virol 81 2 (2009) 264-270
122. Engels E.A., Biggar R.J., Hall H.I., Cross H., Crutchfield A., Finch J.L., et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 123 1 (2008) 187-194
123. Smith N.A., Sabin C.A., Gopal R., Bourboulia D., Labbet W., Boshoff C., et al. Serologic evidence of human herpesvirus 8 transmission by homosexual but not heterosexual sex. J Infect Dis 180 3 (1999) 600-606
124. Malope B.I., MacPhail P., Mbisa G., MacPhail C., Stein L., Ratshikhopha E.M., et al. No evidence of sexual transmission of Kaposi's sarcoma herpes virus in a heterosexual South African population. AIDS 22 4 (2008) 519-526
125. de Sanjose S., Mbisa G., Perez-Alvarez S., Benavente Y., Sukvirach S., Hieu N.T., et al. Geographic variation in the prevalence of Kaposi sarcoma-associated herpesvirus and risk factors for transmission. J Infect Dis 199 10 (2009) 1449-1456
126. Hladik W., Dollard S.C., Downing R.G., Kataaha P., Pellett P.E., Karon J.M., et al. Kaposi's sarcoma in Uganda: risk factors for human herpesvirus 8 infection among blood donors. J Acquir Immune Defic Syndr 33 2 (2003) 206-210
127. Gandhi M., Koelle D.M., Ameli N., Bacchetti P., Greenspan J.S., Navazesh M., et al. Prevalence of human herpesvirus-8 salivary shedding in HIV increases with CD4 count. J Dent Res 83 8 (2004) 639-643
128. Vieira J., Huang M.L., Koelle D.M., and Corey L. Transmissible Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma. J Virol 71 9 (1997) 7083-7087
129. Pauk J., Huang M.L., Brodie S.J., Wald A., Koelle D.M., Schacker T., et al. Mucosal shedding of human herpesvirus 8 in men. New Engl J Med 343 19 (2000) 1369-1377
130. Koelle D.M., Huang M.L., Chandran B., Vieira J., Piepkorn M., and Corey L. Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates. J Infect Dis 176 1 (1997) 94-102
131. Gessain A., Mauclère P., van Beveren M., Plancoulaine S., Ayouba A., Essame-Oyono J.L., et al. Human herpesvirus 8 primary infection occurs during childhood in Cameroon, Central Africa. Int J Cancer 81 2 (1999) 189-192
132. Plancoulaine S., Abel L., van Beveren M., Trégouët D.A., Joubert M., Tortevoye P., et al. Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population. Lancet 356 9235 (2000) 1062-1065
133. Andreoni M., Sarmati L., Nicastri E., El Sawaf G., El Zalabani M., Uccella I., et al. Primary human herpesvirus 8 infection in immunocompetent children. JAMA 287 10 (2002) 1295-1300
134. Butler L.M., Dorsey G., Hladik W., Rosenthal P.J., Brander C., Neilands T.B., et al. Kaposi sarcoma-associated herpesvirus (KSHV) seroprevalence in population-based samples of African children: evidence for at least two patterns of KSHV transmission. J Infect Dis 200 3 (2009) 430-438
135. Taylor M.M., Chohan B., Lavreys L., Hassan W., Huang M.L., Corey L., et al. Shedding of human herpesvirus 8 in oral and genital secretions from HIV-1-seropositive and -seronegative Kenyan women. J Infect Dis 190 3 (2004) 484-488
136. Mbulaiteye S.M., Pfeiffer R.M., Engels E.A., Marshall V., Bakaki P.M., Owor A.M., et al. Detection of kaposi sarcoma-associated herpesvirus DNA in saliva and buffy-coat samples from children with sickle cell disease in Uganda. J Infect Dis 190 8 (2004) 1382-1386
137. Minhas V., Crabtree K.L., Chao A., M'soka T.J., Kankasa C., Bulterys M., et al. Early childhood infection by human herpesvirus 8 in Zambia and the role of human immunodeficiency virus type 1 coinfection in a highly endemic area. Am J Epidemiol 168 3 (2008) 311-320
138. Malope B.I., Pfeiffer R.M., Mbisa G., Stein L., Ratshikhopha E.M., O'Connell D.L., et al. Transmission of Kaposi sarcoma-associated herpesvirus between mothers and children in a South African population. J Acquir Immune Defic Syndr 44 3 (2007) 351-355
139. Dedicoat M., Newton R., Alkharsah K.R., Sheldon J., Szabados I., Ndlovu B., et al. Mother-to-child transmission of human herpesvirus-8 in South Africa. J Infect Dis 190 6 (2004) 1068-1075
140. Mayama S., Cuevas L.E., Sheldon J., Omar O.H., Smith D.H., Okong P., et al. Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer 77 6 (1998) 817-820
141. Beyari M.M., Hodgson T.A., Cook R.D., Kondowe W., Molyneux E.M., Scully C.M., et al. Multiple human herpesvirus-8 infection. J Infect Dis 188 5 (2003) 678-689
142. Cook R.D., Hodgson T.A., Waugh A.C., Molyneux E.M., Borgstein E., Sherry A., et al. Mixed patterns of transmission of human herpesvirus-8 (Kaposi's sarcoma-associated herpesvirus) in Malawian families. J Gen Virol 83 Pt 7 (2002) 1613-1619
143. Triantos D., Horefti E., Paximadi E., Kyriakopoulou Z., Karakassiliotis G., Papanastasiou K., et al. Presence of human herpes virus-8 in saliva and non-lesional oral mucosa in HIV-infected and oncologic immunocompromised patients. Oral Microbiol Immunol 19 3 (2004) 201-204
144. Casper C., Krantz E., Selke S., Kuntz S.R., Wang J., Huang M.L., et al. Frequent and asymptomatic oropharyngeal shedding of human herpesvirus 8 among immunocompetent men. J Infect Dis 195 1 (2007) 30-36
145. Duus K.M., Lentchitsky V., Wagenaar T., Grose C., and Webster-Cyriaque J. Wild-type Kaposi's sarcoma-associated herpesvirus isolated from the oropharynx of immune-competent individuals has tropism for cultured oral epithelial cells. J Virol 78 8 (2004) 4074-4084
146. Webster-Cyriaque J., Duus K., Cooper C., and Duncan M. Oral EBV and KSHV infection in HIV. Adv Dent Res 19 1 (2006) 91-95
147. Wood N.H., and Feller L. The malignant potential of HIV-associated Kaposi sarcoma. Cancer Cell Int 8 (2008) 14
148. Ensoli B., Sgadari C., Barillari G., Sirianni M.C., Stürzl M., and Monini P. Biology of Kaposi's sarcoma. Eur J Cancer 37 10 (2001) 1251-1269
149. Rabkin C.S., Janz S., Lash A., Coleman A.E., Musaba E., Liotta L., et al. Monoclonal origin of multicentric Kaposi's sarcoma lesions. New Engl J Med 336 14 (1997) 988-993
150. Rabkin C.S., Bedi G., Musaba E., Sunkutu R., Mwansa N., Sidransky D., et al. AIDS-related Kaposi's sarcoma is a clonal neoplasm. Clin Cancer Res 1 3 (1995) 257-260
151. Delabesse E., Oksenhendler E., Lebbé C., Vérola O., Varet B., and Turhan A.G. Molecular analysis of clonality in Kaposi's sarcoma. J Clin Pathol 50 8 (1997) 664-668
152. Gill P.S., Tsai Y.C., Rao A.P., Spruck III C.H., Zheng T., Harrington Jr. W.A., et al. Evidence for multiclonality in multicentric Kaposi's sarcoma. Proc Natl Acad Sci USA 95 14 (1998) 8257-8261
153. Judde J.G., Lacoste V., Brière J., Kassa-Kelembho E., Clyti E., Couppié P., et al. Monoclonality or oligoclonality of human herpesvirus 8 terminal repeat sequences in Kaposi's sarcoma and other diseases. J Natl Cancer Inst 92 9 (2000) 729-736
154. Dictor M., Rambech E., Way D., Witte M., and Bendsöe N. Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients. Am J Pathol 148 6 (1996) 2009-2016
155. Huang Y.Q., Li J.J., Zhang W.G., Feiner D., and Friedman-Kien A.E. Transcription of human herpesvirus-like agent (HHV-8) in Kaposi's sarcoma. J Clin Invest 97 12 (1996) 2803-2806
156. Jin Y.T., Tsai S.T., Yan J.J., Chen F.F., Lee W.Y., Li W.Y., et al. Presence of human herpesvirus-like DNA sequence in oral Kaposi's sarcoma. A preliminary PCR study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 81 4 (1996) 442-444
157. Huang Y.Q., Li J.J., Kaplan M.H., Poiesz B., Katabira E., Zhang W.C., et al. Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet 345 8952 (1995) 759-761
158. Feller L., and Lemmer J. Insights into pathogenic events of HIV-associated Kaposi sarcoma and immune reconstitution syndrome related Kaposi sarcoma. Infect Agent Cancer 3 (2008) 1
159. Horenstein M.G., Moontasri N.J., and Cesarman E. The pathobiology of Kaposi's sarcoma: advances since the onset of the AIDS epidemic. J Cutan Pathol 35 2 (2008) 40-44
160. Wen KW, Damania B. Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis. Cancer Lett 2009. doi:10.1016/j.canlet.2009.07.004.
161. Montaner S., Sodhi A., Molinolo A., Bugge T.H., Sawai E.T., He Y., et al. Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Cancer Cell 3 1 (2003) 23-36
162. Verma S.C., and Robertson E.S. Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus. FEMS Microbiol Lett 222 2 (2003) 155-163
163. Schwartz R.A. Kaposi's sarcoma: an update. J Surg Oncol 87 3 (2004) 146-151
164. Iscovich J., Boffetta P., Franceschi S., Azizi E., and Sarid R. Classic kaposi sarcoma: epidemiology and risk factors. Cancer 88 3 (2000) 500-517
165. Lamovec J., and Knuutila S. Kaposi Sarcoma. In: Fletcher C.D.M., Unni K.K., and Mertens F. (Eds). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone (2002), IARC Press, Lyon 170-172
166. Regezi J.A., MacPhail L.A., Daniels T.E., Greenspan J.S., Greenspan D., Dodd C.L., Lozada-Nur F., Heinic G.S., Chinn H., Silverman Jr. S., et al. Oral Kaposi's sarcoma: a 10-year retrospective histopathologic study. J Oral Pathol Med 22 7 (1993) 292-297
167. Ramírez-Amador V., González M., de la Rosa E., Esquivel L., Volkow P., Ochoa F.J., et al. Oral findings in Mexican AIDS patients with cancer. J Oral Pathol Med 22 2 (1993) 87-91
168. Mohanna S., Bravo F., Ferrufino J.C., Sanchez J., and Gotuzzo E. Classic Kaposi's sarcoma presenting in the oral cavity of two HIV-negative Quechua patients. Med Oral Patol Oral Cir Bucal 12 5 (2007) E365-368
169. Hengge U.R., Ruzicka T., Tyring S.K., Stuschke M., Roggendorf M., Schwartz R.A., et al. Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: Epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Infect Dis 2 5 (2002) 281-292
170. Sissolak G., and Mayaud P. AIDS-related Kaposi's sarcoma: epidemiological, diagnostic, treatment and control aspects in sub-Saharan Africa. Trop Med Int Health 10 10 (2005) 981-992
171. Taylor J.F., Templeton A.C., Vogel C.L., Ziegler J.L., and Kyalwazi S.K. Kaposi's sarcoma in Uganda: a clinico-pathological study. Int J Cancer 8 1 (1971) 122-135
172. Duman S., Töz H., Asçi G., Alper S., Ozkahya M., Unal I., et al. Successful treatment of post-transplant Kaposi's sarcoma by reduction of immunosuppression. Nephrol Dial Transplant 17 5 (2002) 892-896
173. Patrikidou A., Vahtsevanos K., Charalambidou M., Valeri R.M., Xirou P., and Antoniades K. Kaposi's sarcoma in the head and neck area. Head Neck 31 2 (2009) 260-268
174. Jindal J.R., Campbell B.H., Ward T.O., and Almagro U.S. Kaposi's sarcoma of the oral cavity in a non-AIDS patient: case report and review of the literature. Head Neck 17 1 (1995) 64-68
175. Pagani D., Bellinvia M., Capaccio P., Scoppio B., Brambilla L., and Pignataro L. An unusual cause of a parotid mass in an immunocompetent host: classic Kaposi's sarcoma. Tumori 95 2 (2009) 248-250
176. Cottoni F., Masala M.V., Piras P., Montesu M.A., and Cerimele D. Mucosal involvement in classic Kaposi's sarcoma. Br J Dermatol 148 6 (2003) 1273-1274
177. Reis-Filho J.S., Souto-Moura C., and Lopes J.M. Classic Kaposi's sarcoma of the tongue: case report with emphasis on the differential diagnosis. J Oral Maxillofac Surg 60 8 (2002) 951-954
178. Puxeddu R., Parodo G., Locci F., Puxeddu I., Manconi P.E., and Ferreli C. Parotid mass as an early sign of Kaposi's sarcoma associated with human herpesvirus 8 infection. J Laryngol Otol 116 6 (2002) 470-473
179. Mwakigonja A.R., Pak F., Pyakurel P., Mosha I.J., Urassa W.K., Kaaya E.E., et al. Oral Kaposi's sarcoma in Tanzania: presentation, immunopathology and human herpesvirus-8 association. Oncol Rep 17 6 (2007) 1291-1299
180. Choussy O., Van Haverbeke C., Babin E., Francois A., Duval-Modeste A.B., and Dehesdin D. Unusual presentation of oropharyngeal Kaposi's sarcoma. Head Neck 30 3 (2008) 411-415
181. Pantanowitz L., and Dezube B.J. Kaposi sarcoma in unusual locations. BMC Cancer 8 (2008) 190
182. Steele N.P., Sampogna D., and Sessions R.B. Kaposi's sarcoma of an intraparotid lymph node leading to a diagnosis of HIV. Laryngoscope 115 5 (2005) 861-863
183. Lager I., Altini M., Coleman H., and Ali H. Oral Kaposi's sarcoma: a clinicopathologic study from South Africa. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96 6 (2003) 701-710
184. Konstantinopoulos P.A., Goldsztein H., Dezube B.J., and Pantanowitz L. Acquired immunodeficiency syndrome related Kaposi's sarcoma eroding the maxillary bone. J Laryngol Otol 122 9 (2008) 993-997
185. Caponetti G., Dezube B.J., Restrepo C.S., and Pantanowitz L. Kaposi sarcoma of the musculoskeletal system: a review of 66 patients. Cancer 109 6 (2007) 1040-1052
186. Lausten L.L., Ferguson B.L., Barker B.F., and Cobb C.M. Oral Kaposi sarcoma associated with severe alveolar bone loss: case report and review of the literature. J Periodontol 74 11 (2003) 1668-1675
187. Castle J.T., and Thompson L.D. Kaposi sarcoma of major salivary gland origin: a clinicopathologic series of six cases. Cancer 88 1 (2000) 15-23
188. Qunibi W., Al-Furayh O., Almeshari K., Lin S.F., Sun R., Heston L., et al. Serologic association of human herpesvirus eight with posttransplant Kaposi's sarcoma in Saudi Arabia. Transplantation 65 4 (1998) 583-585
189. Pak F., Pyakural P., Kokhaei P., Kaaya E., Pourfathollah A.A., Selivanova G., et al. HHV-8/KSHV during the development of Kaposi's sarcoma: evaluation by polymerase chain reaction and immunohistochemistry. J Cutan Pathol 32 1 (2005) 21-27
190. Pyakurel P., Massambu C., Castaños-Vélez E., Ericsson S., Kaaya E., Biberfeld P., et al. Human herpesvirus 8/Kaposi sarcoma herpesvirus cell association during evolution of Kaposi sarcoma. J Acquir Immune Defic Syndr 36 2 (2004) 678-683
191. Vart R.J., Nikitenko L.L., Lagos D., Trotter M.W., Cannon M., Bourboulia D., et al. Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells. Cancer Res 67 9 (2007) 4042-4051
192. Pyakurel P., Pak F., Mwakigonja A.R., Kaaya E., Heiden T., and Biberfeld P. Lymphatic and vascular origin of Kaposi's sarcoma spindle cells during tumor development. Int J Cancer 119 6 (2006) 1262-1267
193. Carroll P.A., Brazeau E., and Lagunoff M. Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation. Virology 328 1 (2004) 7-18
194. Kahn H.J., Bailey D., and Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Mod Pathol 15 4 (2002) 434-440
195. Aoki Y., Jaffe E.S., Chang Y., Jones K., Teruya-Feldstein J., Moore P.S., et al. Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood 93 12 (1999) 4034-4043
196. Brambilla L., Boneschi V., Taglioni M., and Ferrucci S. Staging of classic Kaposi's sarcoma: a useful tool for therapeutic choices. Eur J Dermatol 13 1 (2003) 83-86
197. Cheung M.C., Pantanowitz L., and Dezube B.J. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy. Oncologist 10 6 (2005) 412-426
198. Aversa S.M., Cattelan A.M., Salvagno L., Crivellari G., Banna G., Trevenzoli M., et al. Treatments of AIDS-related Kaposi's sarcoma. Crit Rev Oncol Hematol 53 3 (2005) 253-265
199. Krown S.E. Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma: implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi's sarcoma. J Clin Oncol 22 3 (2004) 399-402
200. Martinez V., Caumes E., Gambotti L., Ittah H., Morini J.P., Deleuze J., et al. Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy. Br J Cancer 94 7 (2006) 1000-1006
201. Portsmouth S., Stebbing J., Gill J., Mandalia S., Bower M., Nelson M., et al. A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma. AIDS 17 11 (2003) F17-F22
202. Bower M., Weir J., Francis N., Newsom-Davis T., Powles S., Crook T., et al. The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma. AIDS 23 13 (2009) 1701-1706
203. Bihl F., Mosam A., Henry L.N., Chisholm III J.V., Dollard S., Gumbi P., et al. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma. AIDS 21 10 (2007) 1245-1252
204. Sullivan R.J., Pantanowitz L., and Dezube B.J. Targeted therapy for Kaposi sarcoma. BioDrugs 23 2 (2009) 69-75
205. Dezube B.J. Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment. Expert Rev Anticancer Ther 2 2 (2002) 193-200
206. Bodsworth N.J., Bloch M., Bower M., Donnell D., and Yocum R. For the International Panretin Gel KS Study Group. Phase III vehicle-controlled, multi-centered study of topical alitretinoin gel 0.1% in cutaneous AIDS-related Kaposi's sarcoma. Am J Clin Dermatol 2 2 (2001) 77-87
207. Martín-Carbonero L., Palacios R., Valencia E., Saballs P., Sirera G., Santos I., et al. Caelyx/Kaposi's Sarcoma Spanish Group. Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin. Clin Infect Dis 47 3 (2008) 410-417
208. Boudreaux A.A., Smith L.L., Cosby C.D., Bason M.M., Tappero J.W., and Berger T.G. Intralesional vinblastine for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome. A clinical trial to evaluate efficacy and discomfort associated with infection. J Am Acad Dermatol 28 1 (1993) 61-65
209. Ramírez-Amador V., Esquivel-Pedraza L., Lozada-Nur F., De la Rosa-García E., Volkow-Fernández P., Súchil-Bernal L., et al. Intralesional vinblastine vs. 3% sodium tetradecyl sulfate for the treatment of oral Kaposi's sarcoma. A double blind, randomized clinical trial. Oral Oncol 38 5 (2002) 460-467
210. Epstein J.B., Cabay R.J., and Glick M. Oral malignancies in HIV disease: changes in disease presentation, increasing understanding of molecular pathogenesis, and current management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100 5 (2005) 571-578
211. Caccialanza M., Marca S., Piccinno R., and Eulisse G. Radiotherapy of classic and human immunodeficiency virus-related Kaposi's sarcoma: results in 1482 lesions. J Eur Acad Dermatol Venereol 22 3 (2008) 297-302
212. Syndikus I., Vinall A., Rogers P., and Spittle M. High dose rate Microselectron moulds for Kaposi sarcoma of the palate. Radiother Oncol 42 2 (1997) 167-170
213. Glesby M.J., Hoover D.R., Weng S., Graham N.M., Phair J.P., Detels R., et al. Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study. J Infect Dis 173 6 (1996) 1477-1480
214. Mocroft A., Youle M., Gazzard B., Morcinek J., Halai R., and Phillips A.N. Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. AIDS 10 10 (1996) 1101-1105
215. Casper C., Krantz E.M., Corey L., Kuntz S.R., Wang J., Selke S., et al. Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial. J Infect Dis 198 1 (2008) 23-30
216. Mazzi R., Parisi S.G., Sarmati L., Uccella I., Nicastri E., Carolo G., et al. Efficacy of cidofovir on human herpesvirus 8 viraemia and Kaposi's sarcoma progression in two patients with AIDS. AIDS 15 15 (2001) 2061-2062
217. Little R.F., Merced-Galindez F., Staskus K., Whitby D., Aoki Y., Humphrey R., et al. A pilot study of cidofovir in patients with kaposi sarcoma. J Infect Dis 187 1 (2003) 149-153
218. Casper C. New approaches to the treatment of human herpesvirus 8-associated disease. Rev Med Virol 18 5 (2008) 321-329
219. Charfi S., Krichen-Makni S., Yaich S., Makni H., Khabir A., Amouri A., et al. Successful treatment of post-renal transplant gastric and pulmonary Kaposi's sarcoma with conversion to rapamycin treatment. Saudi J Kidney Dis Transpl 18 4 (2007) 617-620
220. Volkow P., Zinser J.W., and Correa-Rotter R. Molecularly targeted therapy for Kaposi's sarcoma in a kidney transplant patient: case report, "what worked and what did not". BMC Nephrol 8 (2007) 6
221. Dezube B.J., Sullivan R., and Koon H.B. Emerging targets and novel strategies in the treatment of AIDS-related Kaposi's sarcoma: bidirectional translational science. J Cell Physiol 209 3 (2006) 659-662
222. Chaisuparat R., Hu J., Jham B.C., Knight Z.A., Shokat K.M., and Montaner S. Dual inhibition of PI3Kalpha and mTOR as an alternative treatment for Kaposi's sarcoma. Cancer Res 68 20 (2008) 8361-8368
223. Ahmadpoor P. Human herpesvirus-8 and kaposi sarcoma after kidney transplantation: mechanisms of tumor genesis. Iran J Kidney Dis 3 3 (2009) 121-126
224. El-Agroudy A.E., El-Baz M.A., Ismail A.M., Ali-El-Dein B., El-Dein A.B., and Ghoneim M.A. Clinical features and course of Kaposi's sarcoma in Egyptian kidney transplant recipients. Am J Transplant 3 12 (2003) 1595-1599
225. Foster C.B., Lehrnbecher T., Samuels S., Stein S., Mol F., Metcalf J.A., et al. An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus. Blood 96 7 (2000) 2562-2567
226. Pelser C., Dazzi C., Graubard B.I., Lauria C., Vitale F., and Goedert J.J. Risk of classic Kaposi sarcoma with residential exposure to volcanic and related soils in Sicily. Ann Epidemiol 19 8 (2009) 597-601
227. Goedert J.J., Vitale F., Lauria C., Serraino D., Tamburini M., Montella M., et al. Classical Kaposi's Sarcoma Working Group Risk factors for classical Kaposi's sarcoma. J Natl Cancer Inst 94 22 (2002) 1712-1718
228. Brown E.E., Whitby D., Vitale F., Marshall V., Mbisa G., Gamache C., et al. Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma. Cancer 107 9 (2006) 2282-2290